A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany
Clinical trial NCT02666261 · COMPLETED
Trial details
- NCT number
- NCT02666261
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-03-04
- Primary completion
- 2018-02-28
- Enrollment
- 15000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.